Welcome To Science

SOLTEC HEALTH

Dedicated To Peripheral and Central Nervous System Activation and Regeneration

A New Era in Neuromodulation Technology

 

SOLTEC HEALTH has developed a safe, non-invasive, drug-free system, which can greatly expand the already growing field of neuromodulation.  With our novel technology, it is now possible to influence a region of the nervous system, the brainstem, which includes the autonomic nervous system (ANS).

The effects of SOLTEC’s technology on sleep improvement and sensory restoration in patients with peripheral neuropathy strongly suggest that it not only activates, but also regenerates the respective neural structures.  This is consistent with neuroplasticity, the ability of the nervous system to grow new circuitry.

The SOLTEC•HEALTH System Includes:

Z GEN Description
Z TRACK CARD
SOLTEC Z Card
i

Company Profile

Investor Deck

Supported by Clinical Data

Consumer

A study comprised of sixty-seven subjects who used the SOLTEC System for on average 116 nights (7,772 recordings) demonstrated statistically significant results.

67 Person Study Results Points
Graph depicting the 67 study results

Medical

A double-blind, placebo-controlled study demonstrated that autonomic (parasympathetic) frequency stimulation produced a reduction in pain and numbness in subjects with peripheral neuropathy.

Diabetic Peripheral Neuropathy Symptoms Relieved By Magnetic Neural Entrainment

Steven J. Kavros, DPM, FACCWS, MAPWCA

DPN Study White Paper Image
Peripheral Neuropathy White Paper

SOLTEC HEALTH is led by Dan Cohen, MD, a neurologist, inventor, and strategic marketer.
“I’ve spent a lifetime helping people sleep and I can tell you, the science has changed.”

Dr Dan Cohen photo

Accredited Investors are invited to contact Bob Hiben, CFO, SOLTEC HEALTH for further information on any securities being offered; the Company’s management will also make themselves available to answer questions. No investment decision should be made before carefully reviewing the Company Profile, Management Deck, and associated Risk Disclosures. The final terms of any offering will be found only in the Purchase Agreement as executed by the investor and the Company. Offerings are subject to change or termination at any time.

Email: [email protected]